MICHAEL FANO: Open Payments
NPI 1740394204 · JAMAICA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,162 in 44 payments from 9 companies in 2025. Trend: 2023 $1,172 · 2024 $1,363 · 2025 $1,162
Food & beverage: $1,162
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 16 | $433 |
| ViiV Healthcare Company | 6 | $260 |
| Teva Pharmaceuticals USA, Inc. | 11 | $168 |
| Merck Sharp & Dohme LLC | 5 | $126 |
| Otsuka America Pharmaceutical, Inc. | 2 | $56 |
| Axsome Therapeutics, Inc. | 1 | $34 |
| Lundbeck LLC | 1 | $32 |
| Lilly USA, LLC | 1 | $31 |
| EMD Serono, Inc. | 1 | $23 |
Products named: CABENUVA, Yeztugo, AUSTEDO XR, DOVATO, ABILIFY MAINTENA, GARDASIL 9, PIFELTRO, UZEDY.
Industry payments across NY — which companies pay providers there.
